Genomics

Dataset Information

RAS-mutant AML LSCs originate from GMPs and drive clinical resistance to BH3 mimetics [ATAC-Seq]


ABSTRACT: RAS-mutant AML LSCs originate from GMPs and drive clinical resistance to BH3 mimetics [ATAC-Seq]

PROVIDER: PRJNA1066780 | ENA |

REPOSITORIES: ENA